[{"Assets_0_Q1_USD":7241904000.0,"CommonStockSharesOutstanding_0_Q1_shares":103803581.0,"EarningsPerShareBasic_1_Q1_USD":-0.24,"EarningsPerShareDiluted_1_Q1_USD":-0.24,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-46985000.0,"NetIncomeLoss_1_Q1_USD":-24552000.0,"StockholdersEquity_0_Q1_USD":2907259000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":104449000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":104449000.0,"Ticker":"SYNH","CIK":"1610950","name":"SYNEOS HEALTH, INC.","OfficialName":"Syneos Health Inc. Class A Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8107202548.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]